ODP109 PARATHYROID HORMONE AND 25 OH VITAMINA D IN PREGNANCY: DATA FROM AN ARGENTINEAN COHORT SUPPORTING SUPPLEMENTATION.
Authors: Torres Marta Isabel , Farelo H , Otero P , Di Cugno M , Kozak A , Ruibal G , Rodriguez P , Fenili C , Sequera A ,   V Course Specialist SAEM Alonso de Armiño L, Álvarez G , Anselmo C , Araque S , Barrios V , Belloni J , Blanco C ,   V Course Specialist SAEM Brito Fernãndez P, Burakowski D , Cabral F , Cãceres L , Castillo M S , Cateura M , Cepero M I ,   V Course Specialist SAEM Chaud V, Corbatta C , De La Colina A , De Miguel L , Delgado V , Dominguez C , Dragani V , Fillipini S , Foglino E , Gasparin A , Gerosa P , Golinelli B , Herrero D , Isaack K , Laguarde M , Lalosa L , López M , Lucero V , Mallo M V , Marina C , Minotti F , Mora M E , Palacios M , Paz Pacheco J , Perez Bonetti L , Podadas Gaspa S , Rios E , Rossi O , Sanhueza N ,   Students,   V Course Specialist SAEM Semerena S, Sosa S , Surbando L , Vargas R 
Published: November 2022

Abstract

Vitamin D (Vit D) deficiency has become a global health care issue, as it affects a great number of women during pregnancy and lactation. Vit D levels are critical during pregnancy, being the mother the only source of them for the developing fetus; an enzymatic system for conversion of 25OH VitD into 1-25(OH) 2 VitD is present in the placenta, thus reinforcing the importance of VitD during gestation. VitD deficiency has been associated with obstetric complications and adverse outcomes in offspring, affecting skeletal, immunological and respiratory systems. It is known that prenatal supplements available do not contain enough VitD to fulfil requirements. It is generally accepted that elevated PTH is an indicator of VitD deficiency, and Hysaj O et al (2021) showed that 25OH VitD is a statistically significant determinant of PTH levels in early and late pregnancy.

Aim
To evaluateVitD status and its relationship to parathyroid hormone (PTH) in a cohort of pregnant women representative of multiple Argentinian regions.

Subjects and Methods
Data from samples of 423 pregnant women in 1st and 2nd trimester were collected between 2016 and 2021. VitD was measured in different platforms: DiaSorin Liaison CLIA (n=184), Roche COBAS ECLIA (n=166), Abbott ARCHITECT CMIA (n=33), Biomérieux VIDAS ELFA (n=18) and Siemens CENTAUR CLIA (n=16). PTH (ng/L) was measured in 162 samples by SIEMENS IMMULITE CLIA and Roche COBAS ECLIA. As VitD is light-exposure dependent, we considered warm and high light-exposure season period from December to March and cold and low light season from April to September. VITD (ng/L) levels were classified as Deficient (&lt;20), Insufficient (between 21 and 29) and Sufficient (&gt;30) (Endocrine Society, 2014).

Results
From 423 data collected, 102 were excluded because of lacking information on VitD supplementation. From the remaining non supplemented 321 samples, 48% resulted insufficient, 30% deficient and 22% sufficient for VitD (groups comparison: p&lt; 0. 05, Kruskal Wallis-Dunn test). The seasonal period and pregnancy trimester distributions didn't show significant differences. Similar results of VitD insufficiency were found in the major used platforms, regardless the seasonal period considered. PTH results expressed as median and interquartile range were (ng/L): 32. 0 (13.7-169. 0) in Deficient pregnancies (N=92), 23.7(13.3-88. 0) in Insufficient (n=50) and 18.7 (9.8-55.7) in Sufficient (n=20).

Conclusions
This study shows VitD inadequate levels in 78% in non-supplemented pregnancies, regardless season or measurement platform. Relative elevated levels of PTH were associated to pregnancies with VitD deficiency, evidenciating a regulatory role according to published data. To improve VitD status during pregnancy it would be advisable to pose new strategies for prenatal supplements developed by a multidisciplinary professional team.
Presentation: No date and time listed